This study is testing whether adding a new drug called ivaltinostat to a standard chemotherapy pill (capecitabine) can help control advanced pancreatic cancer for longer. It's for patients whose cancer has not gotten worse after initial treatment with a strong chemotherapy regime…
Phase: PHASE1, PHASE2 • Sponsor: CG Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC